Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

• मुख्य लेखकों: Yunduan Song (लेखक), Yusen Gou (लेखक), Jiameng Gao (लेखक), Dongxin Chen (लेखक), Haibo Zhang (लेखक), Wenjuan Zhao (लेखक), Feng Qian (लेखक), Ajing Xu (लेखक), Yao Shen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migrain...